Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
|Articles|September 1, 2007
- Volume 0 0
Zoster Vaccine
Advertisement
Case Scenario: Zoster VaccineAP is a 70-year-old man who presents to the pharmacy for vaccination information. He is in very good health except for a slight cough and a minor cold, which he is treating with OTC products. At this visit, he inquires about whether he should get his flu shot and any other vaccinations that he may need. Should he receive the zoster vaccine?
Articles in this issue
about 19 years ago
Calming the Symptoms of Menopauseabout 19 years ago
pharmacy TECHNOLOGY productsabout 19 years ago
health-systems PRODUCT newsabout 19 years ago
can you READ these Rxs?about 19 years ago
can you READ these Rxs?about 19 years ago
Generic Times Product Newsabout 19 years ago
compounding HOTLINEabout 19 years ago
Human HRT Leads Compounding Renaissanceabout 19 years ago
Prescription-overdose Deaths Surpass Car-accident Deathsabout 19 years ago
43 Years Later, a DES Case Is Still in the Court SystemAdvertisement
Related to this article
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Bridging the Gap: Pharmacist Experiences Obtaining DEA Licenses
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
4
Comparison of Weight-Based vs Non–Weight-Based Norepinephrine Dosing in Patients With Septic Shock
5